Mark P Ward

11PUBLICATIONS
43CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular, biological, and multi-scale communicationsMolecular targetsBioinformatic methods development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 28, 2025
Crosstalk Between Inflammasome Signalling and Epithelial-Mesenchymal Transition in Cancer and Benign Disease: Mechanistic Insights, Context-Dependence, and Therapeutic Opportunities.

Abdul L Shakerdi, Emma Finnegan, Yin-Yin Sheng

|Oct 22, 2025
Circulating tumour cells are a prognostic indicator in advanced high-grade serous ovarian cancer and are associated with platelets and immune cells following dissemination.

Mark P Ward, Faye Lewis, Catherine O'Gorman

|Jan 25, 2025
Extracellular Vesicles and Tunnelling Nanotubes as Mediators of Prostate Cancer Intercellular Communication.

Jessica K Heatlie, Joanna Lazniewska, Courtney R Moore

|Jan 11, 2025
Components of the Endosome-Lysosome Vesicular Machinery as Drivers of the Metastatic Cascade in Prostate Cancer.

Bukuru Dieu-Donne Nturubika, Jessica Logan, Ian R D Johnson

|Aug 11, 2024
Potential role of the CD39-CD73 ATP-adenosine pathway in platelet mediated dissemination of circulating tumour cells.

Mark P Ward, Sharon A O'Toole, John J O'Leary

|Jun 28, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1.

Jessica M Logan, Ashley M Hopkins, Carmela Martini

Pageof 2

Frequent Collaborators

6 joint publications

John J O'Leary

5 joint publications

Douglas A Brooks

4 joint publications

Sharon O'Toole

3 joint publications

Jean Calleja-Agius